Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.2.1.83 extracted from

  • Hu, X.; Jiang, X.; Aubree, E.; Boulenguer, P.; Critchley, A.T.
    Preparation and in vivo antitumor activity of kappa-carrageenan oligosaccharides (2006), Pharm. Biol., 44, 646-650.
No PubMed abstract available
Search for more literature for 3.2.1.83

Organism

Organism UniProt Comment Textmining
Cytophaga sp.
-
-
-
Cytophaga sp. MCA-2
-
-
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
kappa-carrageenan + H2O low-molecular-weight carrageenan oligosaccharides are obtained. Antitumor activities of the oligosaccharides are tested on Sarcoma 180 tumor transplanted in mice. The carrageenan oligosaccharide show much higher tumor inhibition (70.8%) and catalase activity at a dosage of 100 mg/kg compared with the control group Cytophaga sp. ?
-
 ?
kappa-carrageenan + H2O low-molecular-weight carrageenan oligosaccharides are obtained. Antitumor activities of the oligosaccharides are tested on Sarcoma 180 tumor transplanted in mice. The carrageenan oligosaccharide show much higher tumor inhibition (70.8%) and catalase activity at a dosage of 100 mg/kg compared with the control group Cytophaga sp. MCA-2 ?
-
 ?